Related Experiment Video
Updated: Mar 14, 2026
10:32
Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
19.4K
Repurposing Drugs for Cognition in Schizophrenia.
Y S Yang1,2, S R Marder1,2, M F Green1,2
1VISN22 Mental Illness Research, Education and Clinical Center, VA Greater Los Angeles Healthcare System, Los Angeles, California, USA.
Clinical Pharmacology and Therapeutics
|October 6, 2016
Summary
Current schizophrenia treatments offer minimal cognitive improvement, driving research into new drugs targeting non-dopaminergic systems to address this unmet need.
Area of Science:
- Neuroscience
- Psychiatry
- Pharmacology
Background:
- Approved schizophrenia treatments inadequately address cognitive deficits.
- Cognitive impairment in schizophrenia significantly contributes to patient disability.
- Existing therapies primarily target the dopaminergic system with limited cognitive benefits.
Purpose of the Study:
- To explore novel therapeutic strategies for schizophrenia.
- To identify agents capable of improving cognitive function in schizophrenia patients.
- To investigate non-dopaminergic receptor systems for potential therapeutic targets.
Main Methods:
- Review of current research on drug repurposing for schizophrenia.
- Analysis of studies investigating novel agents targeting non-dopaminergic systems.
- Evaluation of the efficacy of these agents in improving cognitive deficits.
Main Results:
- Current approved treatments for schizophrenia show minimal impact on cognitive deficits.
- Research efforts are focused on repurposing drugs and developing new agents.
- Targeting receptor systems beyond the dopaminergic system shows mixed results.
Conclusions:
- Improving cognitive function in schizophrenia remains a significant unmet medical need.
- Further research into non-dopaminergic pathways is crucial for developing effective treatments.
- Developing novel therapies to enhance cognition is a high-priority area in schizophrenia research.
Related Concept Videos
01:30Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
793
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
793
01:26Psychosis: Goals of Pharmacotherapy
649
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
649
01:28Psychosis and Antipsychotic Drugs: Overview
1.1K
The term "psychosis" refers to a spectrum of mental disorders characterized by abnormal thoughts, perceptions, and behaviors. It can manifest as mood disorders, dementia, delirium with psychotic features, substance-induced psychosis with psychotic features, brief psychotic disorder, delusional disorder, schizoaffective disorder, and schizophrenia. Among all these disorders, schizophrenia is the most common psychotic disorder, affecting 1% of the worldwide population. Psychotic...
1.1K
01:28Drug Therapy
364
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
364
01:22Alzheimer's Disease: Treatment
1.1K
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
1.1K
01:21Antipsychotic Drugs: Therapeutic Uses and Side Effects
1.0K
Antipsychotic drugs primarily block dopamine and serotonin receptors and cholinergic, adrenergic, and histaminergic receptors, thereby reducing hallucinations and delusions in conditions like schizophrenia. However, they can trigger unwanted extrapyramidal effects such as dystonias, Parkinson-like symptoms, and tardive dyskinesia.
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
Despite these side effects, antipsychotics are used therapeutically for various purposes, including managing schizophrenia, preventing nausea and vomiting, curbing...
1.0K